Loading company…
Riskpilot
← Back to search
Sign in
Get full access
HEPAR AS
AS
Active
Org 932104385
Bassengvegen 22, 2390 Moelv
General medical practice activities · NACE 8621
Est. 2023
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 5M
-3% vs 2024
EBITDA margin
63.7%
+14% vs 2024
Equity ratio
67.8%
Financial strength
Net profit 2025
NOK 2,5M
+12% vs 2024
EBITDA — year on year
NOK millions
4M
3M
2M
1M
0M
3M
2023
3M
0%
2024
3M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 5M
-3%
EBITDA
NOK 3,2M
+14%
Net profit
NOK 2,5M
+12%
Total assets
NOK 3,3M
+1%
Equity
NOK 2,3M
+6236%
Employees
1
—
Company information
Legal name
HEPAR AS
Org number
932104385
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
27. september 2023
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drift av legepraksis, undervisning, samt investering i eiendom, aksjer og andre investeringsobjekter.
Contact
Address
Bassengvegen 22, 2390 Moelv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Ringsaker
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
5M
2023
5M
2024
5M
2025
EBITDA
NOK millions
0M
1M
2M
3M
3M
3M
2023
3M
2024
3M
2025
Income statement
NOK thousands
Item
2023
2024
2025
Revenue
4 770
5 171
5 023
Staff expenses
−778
−1 165
−597
EBITDA
2 831
2 812
3 198
Depreciation & amort.
−67
−52
−58
EBIT
2 765
2 760
3 139
Net financials
−35
85
40
Profit before tax
2 729
2 845
3 179
Tax
601
628
699
Net profit
2 129
2 217
2 479
Balance sheet
NOK thousands
Item
2023
2024
2025
Total assets
2 317
3 295
3 322
Equity
41
36
2 252
Long-term debt
1 752
2 979
343
Short-term debt
524
280
727
Total debt
2 276
3 259
1 069
Financial ratios
5-year trend
EBITDA margin
63.7%
This company
15.8%
Market median
+303% vs market
2023
2025
Equity ratio
67.8%
This company
38.2%
Market median
+77% vs market
2023
2025
Return on equity
110.1%
This company
18.4%
Market median
+498% vs market
2023
2025
Net profit margin
49.4%
This company
8.1%
Market median
+510% vs market
2023
2025
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
2023
2025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SB
Sindre Barli
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
HEPAR AS
(this company)
MOELV LEGESENTER AS
Board network connections
Board members of HEPAR AS also hold positions in
0
other companies.
Person
Role here
Other companies
Sindre Barli
Chief Executive Officer
0 companies